
Blockbuster Drugs Power Growth
Several key medicines fueled this strong performance:
- Entresto: $2.26 billion (+22%)
- Cosentyx: $1.53 billion (+18%)
- Kisqali: $956 million (+56%)
- Leqvio: $257 million (+72%)
Moreover, Novartis continued to focus on four high-impact areas like cardiovascular, immunology, neuroscience, and oncology. At the same time, it increased investments in cutting-edge platforms like gene therapy, radioligand therapy, and xRNA. The company also pushed for deeper market penetration in the US, China, Germany, and Japan.
Cash Flow Up, But Debt Grows
Free cash flow jumped 66% to $3.4 billion. However, net debt rose to $22.3 billion. This increase was mainly due to a $5.3 billion dividend payout, share repurchases, and investments in intangible assets.
Growth Outlook Remains Strong
Looking ahead, Novartis plans to accelerate growth through innovation and new product launches. It remains committed to R&D, digital technologies, and global expansion. Backed by strong cash generation and solid credit ratings, the company remains well-positioned for the rest of the year.
Vas Narasimhan, CEO of Novartis commented,
“Novartis has had a strong start to the year, delivering a +15% cc increase in sales and a +27% cc rise in core operating income in Q1. Our priority brands, including Kisqali, Kesimpta and Leqvio, continue to show strong momentum, which we anticipate will drive our growth through 2030 and beyond. We also achieved significant innovation milestones in the quarter, with new approvals for Pluvicto in the pre-taxane setting, Vanrafia for IgA nephropathy, and Fabhalta for C3G. Additionally, we completed global submissions for remibrutinib in CSU, the first indication for this promising pipeline-in-a-pill. We remain focused on advancing our leading pipeline and confident in achieving our growth outlook.”
Novartis on Track to Meet 2025 Sustainability Goals
Novartis is making steady progress toward its environmental goals. The company has already met its 2025 targets for reducing water use and waste. The Taskforce on Nature-related Financial Disclosures (TNFD) framework guides its broader sustainability efforts, showing a deep commitment to protecting the planet.

Big Cuts in Carbon Emissions
Novartis is cutting its carbon footprint aggressively. It plans to reach carbon neutrality in Scope 1 and 2 emissions by 2025. It follows the Science-Based Targets initiative and supports global efforts to limit climate change to 1.5°C.
By 2030, it aims to slash emissions by 90% from 2022 levels. The company also targets a 42% cut in Scope 3 emissions from suppliers and product use.
Scope Emissions
- In 2023, Scope 1 and 2 emissions totaled 298 tCO₂e, and Scope 3 emissions were 4,529 tCO₂e.
Most of the company’s environmental impact, about 95%, comes from direct operations such as land use, water use, and upstream emissions.

- Novartis intends to achieve net-zero emissions across its entire value chain by 2040.

Clean Energy Initiatives
The pharma giant plans to switch to 100% renewable electricity by 2025. To meet this goal, it’s investing in clean energy projects like biomass steam systems, electric boilers, solar thermal energy, and electric vehicles for its fleet.
The company also works closely with suppliers to add environmental standards to its contracts.
Water and Waste Goals Achieved
Novartis has reduced water usage at key sites, especially in water-stressed regions. It ensures no harmful impacts on water quality from its factories, labs, or suppliers.
On the waste front, the company plans to reduce disposal by 30%, making its operations cleaner and more efficient.
New Focus on Nature and Raw Materials
The company is expanding its efforts to protect nature and improve raw material sourcing. Some measures include biodiversity assessments at sites near sensitive ecosystems and creating nature management plans where needed.
Additionally, it’s shifting to more sustainable materials, starting with paper-based packaging.

Novartis is building a greener future through innovation, strong partnerships, and responsible action. From carbon cuts to water savings, the company is proving that environmental progress and business growth can go hand in hand.
- ALSO READ: Pfizer Plans to Reach Net Zero by 2040
AstraZeneca’s Q1 2025: Sales and Profit Soar on Strong Drug Performance
AstraZeneca posted a 10% rise in revenue at constant exchange rates, reaching $13.59 billion in Q1 2025, up from $12.68 billion last year. This growth came from strong demand for cancer and biopharma drugs across all key markets. The company’s net profit grew by 34% to $2.92 billion.

Tagrisso Leads the Pack
Tagrisso, AstraZeneca’s top lung cancer drug, generated $1.68 billion in sales. It was the company’s highest-selling medicine and the biggest driver of growth this quarter.
Furthermore, AstraZeneca saw strong R&D progress with five positive Phase III trials and 13 new drug approvals in major regions. Key oncology trials included DESTINY-Breast09, SERENA-6, and MATTERHORN.
Smart Deals to Fuel Long-Term Growth
In the first quarter of 2025, AstraZeneca made several smart business moves to strengthen its pipeline and technology base. It is heavily investing in cutting-edge technologies and expanding its global research and development (R&D) presence. These moves are aimed at driving long-term growth and staying ahead in the biopharma space.
JV for Vaccine Launch
- Launched a vaccine joint venture in China with BioKangtai and entered research partnerships with Syneron Bio and Tempus AI to boost innovation in cancer treatment.
Advancing Cell Therapy
- Proposed to acquire EsoBiotec to enter the in-vivo cell therapy space. EsoBiotec’s technology allows for “off-the-shelf” cell therapies, meaning ready-to-use treatments that don’t require custom patient cells.
Exploring Novel Drug Technologies
- Partnered with Harbour BioMed to develop multi-specific biologics, which can target multiple disease pathways at once.
- Teamed up with Syneron to create macro-cyclic peptides, a new type of molecule that could improve how drugs work in the body.
Improving Drug Delivery Methods
- Gained exclusive rights to ALT-B4 from Alteogen. This technology helps deliver drugs under the skin instead of by IV.
- Working on subcutaneous (under-the-skin) versions of several cancer drugs, making treatment faster and more comfortable for patients.
AstraZeneca’s Q1 2025 results show a strong push toward future-ready healthcare solutions. With new partnerships, acquisitions, and delivery tech, the company is setting itself up for long-term success in global markets.
Pascal Soriot, Chief Executive Officer, AstraZeneca, commented on the results:
“Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company.
Already this year we have announced five positive Phase III study readouts, including most recently the highly anticipated DESTINYBreast09 for Enhertu, as well as SERENA-6 for camizestrant and MATTERHORN for Imfinzi; the latter two of these will feature in the ASCO 2025 plenary sessions, reflecting the significance of these data to the oncology community.
Our company is firmly committed to investing and growing in the US and we continue to benefit from our broad-based source of revenue and global manufacturing footprint, including eleven production sites in the US covering small molecules, biologics as well as cell therapy. Additionally, we have even greater US investment in manufacturing and R&D planned, leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress toward our ambition of eighty billion dollars in Total Revenue by 2030.”
AstraZeneca is Driving Sustainability with Science and Action
AstraZeneca is making major progress on its journey to a net-zero future. Through its ambitious “Ambition Zero Carbon” strategy, the company is investing $1 billion to cut emissions, switch to clean energy, and lead the healthcare sector toward a more sustainable model.
- AstraZeneca plans to go carbon negative by 2030.
Scope 1 and 2 Emissions
The company has significantly reduced its direct emissions. Gross Scope 1 and 2 GHG emissions (market-based) dropped from 200,838 tonnes in 2023 to 139,594 tonnes in 2024, highlighting substantial progress in cutting emissions across its operations.
Since 2015, AstraZeneca has reduced its Scope 1 and 2 greenhouse gas emissions by an impressive 77.5%. The company remains firmly on track to meet its ambitious target of a 98% reduction in these direct emissions by 2026.

Scope 3 Emissions
In 2024, AstraZeneca reported 5,897,822 tonnes of Scope 3 emissions, slightly down from 5,917,160 tonnes in 2023, showing a small but steady reduction in indirect emissions.
This progress reflects AstraZeneca’s strong commitment to climate action through clean energy use and operational efficiency.
Electric Fleets and Smarter Energy Use
- 63% of company vehicles are now fully electric; the goal is 100% by 2025
- 97% of the electricity used at company sites comes from renewable sources
- Energy consumption has dropped 20% since 2015
- Energy productivity has jumped 147%, showing better efficiency with less energy use
AstraZeneca’s progress shows how innovation, science, and sustainability can work hand-in-hand to build a healthier planet.

Clean Heat for Global Sites
AstraZeneca is replacing fossil fuels with clean, renewable heat at its sites around the world:
- US: Partnered with Vanguard Renewables to turn food and farm waste into renewable natural gas. Will heat all US R&D and manufacturing sites by 2026.
- UK: Working with Future Biogas to supply green gas to major UK sites (Macclesfield, Cambridge, Luton, Speke).
- China: Partnering with China Resources Gas to bring clean heat to its Wuxi plant, aiming to cut emissions in China by up to 80%. This is the first clean heat deal of its kind in the Chinese healthcare industry.
A Focus on Circular Solutions
AstraZeneca is cutting waste and reusing more materials. Instead of throwing things away, it focuses on recycling and the smarter use of resources.
The company is reducing single-use plastics. It’s also improving packaging to be more eco-friendly. In addition, AstraZeneca is working closely with suppliers to make greener choices.
Its factories now reuse materials and recycle more. As a result, operations are cleaner and more efficient. These efforts help protect the planet and inspire change across the healthcare industry.
So, Who Won the Profit and Net-Zero Game?
Novartis outperformed financially due to blockbuster drugs and strong cost discipline, while AstraZeneca led the way on sustainability, with steeper carbon cuts and near-complete renewable energy use.
The post Big Pharma Showdown: Novartis vs. AstraZeneca in Q1 2025 Profits and Emissions Cuts appeared first on Carbon Credits.
Carbon Footprint
Finding Nature Based Solutions in Your Supply Chain
Carbon Footprint
How Climate Change Is Raising the Cost of Living
Americans are paying more for insurance, electricity, taxes, and home repairs every year. What many people may not realize is that climate change is already one of the drivers behind those rising costs.
For many households, climate change is no longer just an environmental issue. It is becoming a cost-of-living issue. While climate impacts like melting glaciers and shrinking polar ice can feel distant from everyday life, the financial effects are already showing up in monthly budgets across the country.
Today, a larger share of household income is consumed by fixed costs such as housing, insurance, utilities, and healthcare. (3) Climate change and climate inaction are adding pressure to many of those expenses through higher disaster recovery costs, rising energy demand, infrastructure repairs, and increased insurance risk.
The goal of this article is to help connect climate change to the everyday financial realities people already experience. Regardless of where someone stands on climate policy, it is important to recognize that climate change is already increasing costs for households, businesses, and taxpayers across the United States.
More conservative estimates indicate that the average household has experienced an increase of about $400 per year from observed climate change, while less conservative estimates suggest an increase of $900.(1) Those in more disaster-prone regions of the country face disproportionate costs, with some households experiencing climate-related costs averaging $1,300 per year.(1) Another study found that climate adaptation costs driven by climate change have already consumed over 3% of personal income in the U.S. since 2015.(9) By the end of the century, housing units could spend an additional $5,600 on adaptation costs.(1)
Whether we realize it or not, Americans are already paying for climate change through higher insurance premiums, energy costs, taxes, and infrastructure repairs. These growing expenses are often referred to as climate adaptation costs.
Without meaningful climate action, these costs are expected to continue rising. Choosing not to invest in climate action is also choosing to spend more on climate adaptation.
Here are a few ways climate change is already increasing the cost of living:
- Higher insurance costs from more frequent and severe storms
- Higher energy use during longer and hotter summers
- Higher electricity rates tied to storm recovery and grid upgrades
- Higher government spending and taxpayer-funded disaster recovery costs
The real debate is not whether climate change costs money. Americans are already paying for it. The question is where we want those costs to go. Should we invest more in climate action to help reduce future climate adaptation costs, or continue paying growing recovery and adaptation expenses in everyday life?
How Climate Change Is Increasing Insurance Costs
There is one industry that closely tracks the financial impact of natural disasters: insurance. Insurance companies are focused on assessing risk, estimating damages, and collecting enough revenue to cover losses and remain financially stable.
Comparing the 20-year periods 1980–1999 and 2000–2019, climate-related disasters increased 83% globally from 3,656 events to 6,681 events. The average time between billion-dollar disasters dropped from 82 days during the 1980s to 16 days during the last 10 years, and in 2025 the average time between disasters fell to just 10 days. (6)
According to the reinsurance firm Munich Re, total economic losses from natural disasters in 2024 exceeded $320 billion globally, nearly 40% higher than the decade-long annual average. Average annual inflation-adjusted costs more than quadrupled from $22.6 billion per year in the 1980s to $102 billion per year in the 2010s. Costs increased further to an average of $153.2 billion annually during 2020–2024, representing another 50% increase over the 2010s. (6)
In the United States, billion-dollar weather and climate disasters have also increased significantly. The average number of billion-dollar disasters per year has grown from roughly three annually during the 1980s to 19 annually over the last decade. In 2023 and 2024, the U.S. recorded 28 and 27 billion-dollar disasters respectively, both setting new records. (6)
The growing impact of climate change is one reason insurance costs continue to rise. “There are two things that drive insurance loss costs, which is the frequency of events and how much they cost,” said Robert Passmore, assistant vice president of personal lines at the Property Casualty Insurers Association of America. “So, as these events become more frequent, that’s definitely going to have an impact.” (8)
After adjusting for inflation, insurance costs have steadily increased over time. From 2000 to 2020, insurance costs consistently grew faster than the Consumer Price Index due to rising rebuilding costs and weather-related losses.(3) Between 2020 and 2023 alone, the average home insurance premium increased from $75 to $360 due to climate change impacts, with disaster-prone regions experiencing especially steep increases.(1) Since 2015, homeowners in some regions affected by more extreme weather have seen home insurance costs increased by nearly 57%.(1) Some insurers have also limited or stopped offering coverage in high-risk areas.(7)
For many families, rising insurance costs are no longer occasional financial burdens. They are becoming recurring monthly expenses tied directly to growing climate risk.
How Rising Temperatures Increase Household Energy Costs

The financial impacts of climate change extend beyond insurance. Rising temperatures are also changing how much energy Americans use and how utilities plan for future electricity demand.
Between 1950 and 2010, per capita electricity use increased 10-fold, though usage has flattened or slightly declined since 2012 due to more efficient appliances and LED lighting. (3) A significant share of increased energy demand comes from cooling needs associated with higher temperatures.
Over the last 20 years, the United States has experienced increasing Cooling Degree Days (CDD) and decreasing Heating Degree Days (HDD). Nearly all counties have become warmer over the past three decades, with some areas experiencing several hundred additional cooling degree days, equivalent to roughly one additional degree of warmth on most days. (1) This trend reflects a warming climate where air conditioning demand is increasing while heating demand generally declines. (4)
As temperatures continue rising, households are expected to spend more on cooling than they save on heating. The U.S. Energy Information Administration (EIA) projects that by 2050, national Heating Degree Days will be 11% lower while Cooling Degree Days will be 28% higher than 2021 levels. Cooling demand is projected to rise 2.5 times faster than heating demand declines. (5)
These projections come from energy and infrastructure experts planning for future electricity demand and grid capacity needs. Utilities and grid operators are already preparing for higher peak summer electricity loads caused by rising temperatures. (5)
Longer and hotter summers also affect how homes and buildings are designed. Buildings constructed for past climate conditions may require upgrades such as larger air conditioning systems, stronger insulation, and improved ventilation to remain comfortable and energy efficient in the future. (10)
For many households, this means higher monthly utility bills and potentially higher long-term home improvement costs as temperatures continue to rise.
How Climate Change Affects Electricity Rates
On an inflation-adjusted basis, average U.S. residential electricity rates are slightly lower today than they were 50 years ago. (2) However, climate-related damage to utility infrastructure is creating new upward pressure on electricity costs.
Electric utilities rely heavily on above-ground poles, wires, transformers, and substations that can be damaged by hurricanes, storms, floods, and wildfires. Repairing and upgrading this infrastructure often requires substantial investment.
As a result, utilities are increasing electricity rates in response to wildfire and hurricane events to fund infrastructure repairs and future mitigation efforts. (1) The average cumulative increase in per-household electricity expenditures due to climate-related price changes is approximately $30. (1)
While this increase may appear modest today, utility costs are expected to rise further as climate-related infrastructure damage becomes more frequent and severe.
How Climate Disasters Increase Government Spending and Taxes
Extreme weather events also damage public infrastructure, including roads, schools, bridges, airports, water systems, and emergency services infrastructure. Recovery and rebuilding costs are often funded through taxpayer dollars at the federal, state, and local levels.
The average annual government cost tied to climate-related disaster recovery is estimated at nearly $142 per household. (1) States that frequently experience hurricanes, wildfires, tornadoes, or flooding can face even higher public recovery costs.
These expenses affect taxpayers whether they personally experience a disaster or not. Climate-related recovery spending can increase pressure on public budgets, emergency management systems, and infrastructure funding nationwide.
Reducing Climate Costs Through Climate Action
While this article focuses on the growing financial costs associated with climate change, the issue is not only about money for many people. It is also about recognizing our environmental impact and taking responsibility for reducing it in order to help preserve a healthy planet for future generations.
While individuals alone cannot solve climate change, collective action can help reduce future climate adaptation costs over time.
For those interested in taking action, there are three important steps:
- Estimate your carbon footprint to better understand the emissions connected to your lifestyle and activities.
- Create a plan to gradually reduce emissions through energy efficiency, cleaner technologies, and more sustainable choices.
- Address remaining emissions by supporting verified carbon reduction projects through carbon credits.
Carbon credits are one of the most cost-effective tools available for climate action because they help fund projects that generate verified emission reductions at scale. Supporting global emission reduction efforts can help reduce the long-term impacts and costs associated with climate change.
Visit Terrapass to learn more about carbon footprints, carbon credits, and climate action solutions.
The post How Climate Change Is Raising the Cost of Living appeared first on Terrapass.
Carbon Footprint
Carbon credit project stewardship: what happens after credit issuance
A carbon credit purchase is not a transaction that closes at issuance. The credit may be retired, the certificate filed, and the reporting box ticked. But on the ground, in the forest, in the field, and in the community, the work continues. It endures for years. In many cases, for decades.
![]()
-
Climate Change9 months ago
Guest post: Why China is still building new coal – and when it might stop
-
Greenhouse Gases9 months ago
Guest post: Why China is still building new coal – and when it might stop
-
Greenhouse Gases2 years ago嘉宾来稿:满足中国增长的用电需求 光伏加储能“比新建煤电更实惠”
-
Climate Change2 years ago嘉宾来稿:满足中国增长的用电需求 光伏加储能“比新建煤电更实惠”
-
Climate Change2 years ago
Bill Discounting Climate Change in Florida’s Energy Policy Awaits DeSantis’ Approval
-
Renewable Energy7 months agoSending Progressive Philanthropist George Soros to Prison?
-
Carbon Footprint2 years agoUS SEC’s Climate Disclosure Rules Spur Renewed Interest in Carbon Credits
-
Greenhouse Gases10 months ago
嘉宾来稿:探究火山喷发如何影响气候预测

